基于模型的元分析,使用隐性变量建模来设定系统性红斑狼新疗法的基准
Kosalaram Goteti1, Ramon Garcia2, William R Gillespie2
1EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts, USA.
CPT: pharmacometrics & systems pharmacology
|December 5, 2023
概括
一个新的基于模型的元分析 (MBMA) 基准系统性红斑狼 (SLE) 治疗. 这种定量框架有助于将研究药物与SLE的标准疗法进行比较.
科学领域:
- 类风湿病学 类风湿病学
- 临床药理学 临床药理学
- 生物统计学 生物统计学
背景情况:
- 缺乏用于比较全身性红斑狼 (SLE) 治疗的定量框架.
- 针对SLE的研究药物需要与现有疗法进行强有力的疗效基准.
研究的目的:
- 开发一个定量框架,用于对SLE治疗疗效进行比较.
- 确定影响SLE治疗结果的临床重要共变量.
主要方法:
- 在潜在变量模型框架内使用基于模型的元分析 (MBMA).
- 分析了25个SLE临床试验 (81个治疗臂,16种药物) 的综合数据.
- 贝叶斯的MBMA使用了先前开发的SLE隐性变量模型,用于复合端点.
主要成果:
- MBMA成功地将16种不同的SLE药物与安慰剂进行了比较.
- 对几种药物进行了剂量效应关系建模,其他药物被视为离散剂量效应.
- 该模型提供了对各种SLE治疗方法的最大疗效的定量比较.
结论:
- 该MBMA提供了一种新的定量方法来评估SLE治疗方法.
- 该框架有助于理解SLE等慢性疾病的复合终点轨迹.
- 这种方法促进了新SLE研究药物的基于模型的药物开发.
相关概念视频
Mechanistic Models: Compartment Models in Individual and Population Analysis
43
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
43
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
56
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
56
Comparing the Survival Analysis of Two or More Groups
197
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
197


